Chiu Wei-Yih, Yang Chih-Chao, Huang I-Chueh, Huang Tien-Shang
Department of Internal Medicine, College of Medicine, National Taiwan University and National Taiwan University Hospital, Taipei, Taiwan.
Dysphagia. 2004 Spring;19(2):120-4. doi: 10.1007/s00455-003-0510-z.
Myopathy is frequently associated with thyrotoxicosis. Skeletal muscles are predominantly involved in thyrotoxic myopathy, but dysphagia is extremely rare. We report three cases of thyrotoxicosis with dysphagia and review of the literature of the past 30 years. Most of these patients had antecedent muscle weakness before the onset of dysphagia although some suffered from a sudden onset of bulbar palsy. Either a myopathic or neuropathic pattern was found on electromyography. The incidence of oropharyngeal dysphagia was higher than that of esophageal motility dysfunction. Aspiration pneumonia occurred more accompanied by oropharyngeal dysphagia. The swallowing disorder could be resolved completely within 3 weeks after treatment for thyrotoxicosis. In light of these clinical experiences, early intensive treatment that includes antithyroid agent, beta-blocker, and Lugol solution may be necessary.
肌病常与甲状腺毒症相关。甲状腺毒症性肌病主要累及骨骼肌,但吞咽困难极为罕见。我们报告3例伴有吞咽困难的甲状腺毒症病例,并回顾过去30年的文献。这些患者大多数在吞咽困难发作前有肌无力病史,尽管有些患者突发延髓麻痹。肌电图检查发现呈肌病或神经病模式。口咽吞咽困难的发生率高于食管动力障碍。吸入性肺炎更多伴有口咽吞咽困难。甲状腺毒症治疗后3周内吞咽障碍可完全缓解。鉴于这些临床经验,可能需要早期强化治疗,包括抗甲状腺药物、β受体阻滞剂和卢戈氏液。